Anamaria Brozovic

10PUBLICATIONS
33CO-AUTHORS
Molecular targetsCheminformatics and quantitative structure-activity relationshipsCharacterisation of biological macromoleculesNatural products and bioactive compoundsCancer therapy (excl. chemotherapy and radiation therapy)
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (10)

|Nov 04, 2025
Core-shell hydrogel microspheres with sequential drug release and magnetothermal synergy for drug-resistant ovarian cancer.

Peinan Yin, Anamaria Brozovic, Wei Zhang

|Sep 27, 2025
Guanidino-Aryl Derivatives: Binding to DNA, RNA and G-Quadruplex Structure and Antimetabolic Activity.

Davor Margetić, Petra Jadrijević-Mladar, Anamaria Brozovic

|May 11, 2024
Distinctive Nucleic Acid Recognition by Lysine-Embedded Phenanthridine Peptides.

Josipa Matić, Patryciusz Piotrowski, Lucija Vrban

|Dec 26, 2023
Oleuropein in olive leaf, branch, and stem extracts: stability and biological activity in human cervical carcinoma and melanoma cells.

Đani Benčić, Monika Barbarić, Ana Mornar

|Sep 17, 2023
Carboplatin-induced upregulation of pan β-tubulin and class III β-tubulin is implicated in acquired resistance and cross-resistance of ovarian cancer.

Margareta Pernar Kovač, Vanja Tadić, Juran Kralj

|Jan 30, 2023
Transcriptome analysis of newly established carboplatin-resistant ovarian cancer cell model reveals genes shared by drug resistance and drug-induced EMT.

Juran Kralj, Margareta Pernar Kovač, Sanja Dabelić

Pageof 2

Frequent Collaborators

3 joint publications

Vanja Tadić

2 joint publications

Monika Barbarić

2 joint publications

Robert Vianello

2 joint publications

Marijana Radić Stojković